These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12385921)

  • 21. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
    Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
    JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
    Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.
    Carraro JC; Raynaud JP; Koch G; Chisholm GD; Di Silverio F; Teillac P; Da Silva FC; Cauquil J; Chopin DK; Hamdy FC; Hanus M; Hauri D; Kalinteris A; Marencak J; Perier A; Perrin P
    Prostate; 1996 Oct; 29(4):231-40; discussion 241-2. PubMed ID: 8876706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).
    Preuss HG; Marcusen C; Regan J; Klimberg IW; Welebir TA; Jones WA
    Int Urol Nephrol; 2001; 33(2):217-25. PubMed ID: 12092634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.
    Gerber GS; Zagaja GP; Bales GT; Chodak GW; Contreras BA
    Urology; 1998 Jun; 51(6):1003-7. PubMed ID: 9609640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
    Marberger MJ
    Urology; 1998 May; 51(5):677-86. PubMed ID: 9610579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.
    Giannakopoulos X; Baltogiannis D; Giannakis D; Tasos A; Sofikitis N; Charalabopoulos K; Evangelou A
    Adv Ther; 2002; 19(6):285-96. PubMed ID: 12665049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological changes in prostatic tissue of patients with benign prostatic hyperplasia treated with permixon].
    Sivkov AV; Kudriavtsev IuV; Medvedev AA; Razumov SV; Kochetov SA
    Urologiia; 2004; (5):10-6. PubMed ID: 15560155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Bauer HW; Casarosa C; Cosci M; Fratta M; Blessmann G
    MMW Fortschr Med; 1999 Jun; 141(25):62. PubMed ID: 10897913
    [No Abstract]   [Full Text] [Related]  

  • 31. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia.
    Vela-Navarrete R; Escribano-Burgos M; Farré AL; García-Cardoso J; Manzarbeitia F; Carrasco C
    J Urol; 2005 Feb; 173(2):507-10. PubMed ID: 15643230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.
    Roehrborn CG; Marks LS; Fenter T; Freedman S; Tuttle J; Gittleman M; Morrill B; Wolford ET
    Urology; 2004 Apr; 63(4):709-15. PubMed ID: 15072886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
    J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)].
    Schilcher H
    Wien Med Wochenschr; 1999; 149(8-10):236-40. PubMed ID: 10483690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial.
    Sengupta G; Hazra A; Kundu A; Ghosh A
    Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia.
    Marks LS; Tyler VE
    Urology; 1999 Mar; 53(3):457-61. PubMed ID: 10096366
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia.
    Pytel YA; Vinarov A; Lopatkin N; Sivkov A; Gorilovsky L; Raynaud JP
    Adv Ther; 2002; 19(6):297-306. PubMed ID: 12665050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.